http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08271-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 1994-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_255038f5e49e40e972d8805b68ae0f48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_767230f6d0f5f620ac813e9e685ec264 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b15c2ca0803d4a4858cc28be9615d063 |
| publicationDate | 1996-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08271-A |
| titleOfInvention | Novel polypeptide, method for producing the same, DNA encoding the polypeptide, vector comprising the DNA, host cell transformed with the vector, antibody of the polypeptide, and pharmaceutical composition containing the peptide or antibody Stuff |
| abstract | (57) [Summary] [Structure] 48 produced by the human glioblastoma cell line. Novel polypeptide consisting of 3 amino acids, method for producing the same, DNA encoding the polypeptide, and DNA thereof A fragment that selectively hybridizes to a sequence, a replication or expression vector consisting of the DNA, a host cell transformed with the vector, an antibody of the polypeptide, And a pharmaceutical composition containing the peptide or antibody thereof. [Effects] The polypeptide of the present invention is a disease relating to dysgenesis or abnormal proliferation of glia, neurons or hematopoietic cells, or a decrease or enhancement of immune system or nervous system function (inflammatory disease, hematopoietic stem cell decrease after bone marrow transplantation). , White blood cells, platelets, B cell or T cell depletion, anemia, infection, cancer, AIDS after radiation treatment or chemotherapy Etc.) or a tissue repairing agent (a therapeutic agent for myolysis, a tissue repairing agent after muscle damage, etc.). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100655244-B1 |
| priorityDate | 1994-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 607.